Competition

Competition — Who Can Hurt RS Technologies, and Who It Can Beat

Competitive Bottom Line

RS Technologies has a real moat in one segment and a borrowed one in the other two. Reclaim is a global #1 (~33% share) at 36.9% segment operating margin, above 35% through every cycle for nine years — that combination of share, margin durability and a chemistry-and-qualification barrier is a genuine economic moat. Prime wafer and the equipment rollup are not moated; they ride on (a) Chinese state support for GRITEK and (b) acquired-niche margins that are average at best.

The competitor that matters most is not Shin-Etsu, SUMCO, GlobalWafers or Siltronic — RST is not in their league in prime wafers. It is Ferrotec (6890), the only listed name whose mix straddles reclaim, silicon parts and quartz crucibles the way RST's portfolio does, and the one most able to take reclaim share if pricing or qualification cycles open up.

The Right Peer Set

The peer set has to be split because RST competes in two distinct profit pools with completely different structures.

For the prime wafer business, the peers are the global top-5 oligopoly — Shin-Etsu Chemical (4063), SUMCO (3436), GlobalWafers (6488.TWO), Siltronic (WAF.DE), SK Siltron (Korea, unlisted). RST competes with none of them in 200mm/300mm prime wafers at global scale; its prime business (GRITEK in China + the 39%-owned SGRS 12-inch JV) sells almost entirely into the Chinese mature-node demand pool that the top-5 cannot freely serve under US export controls. They are the right benchmark for what good prime-wafer economics look like — and for what RST's prime segment is not.

For the reclaim wafer business, the only listed comparable with material reclaim exposure is Ferrotec Holdings (6890). Mimasu Semiconductor (8155), Kinik (1560.TW), Phoenix Silicon (6164.TWO) and the various private reclaim shops (Pure Wafer, Optim Wafer Services, KST World) are either too small, too fragmented, or not publicly disclosed enough for a clean comp.

Market cap and EV translated to ¥M at FX rates as of 2026-05-15 (frankfurter.app/ECB; TWD at static 0.0330 USD/TWD). RST: ¥6,640 × 26.46M shares = ¥175.7bn mkt cap; net cash ¥76.0bn; EV ≈ ¥99bn includes minorities and other adjustments. RST EBITDA is segment EBIT ¥14.3bn + D&A ¥5.5bn ≈ ¥19.8bn. Source: data/competition/peer_valuations.json (Yahoo quoteSummary 2026-05-15).

Three reads of this peer chart:

RST sits in the bottom-left — cheap on EV/Sales (1.3x), middle-of-the-pack on EBITDA margin (25.8%). The cheapness is consistent with the consolidated mix (only ~36% of revenue is the high-margin reclaim segment; the rest is China-prime and the camera-module rollup). The 25.8% EBITDA margin understates the reclaim segment's true earning power because it blends three businesses with very different economics — see Where The Company Wins.

Ferrotec is the most relevant comp — same country, same diversified-materials mix, also has reclaim and silicon parts exposure, also has Chinese growth optionality. Trading at 2.1x EV/Sales and 10.9x EV/EBITDA on a 19.6% blended EBITDA margin. RST is cheaper on EV/Sales but slightly more expensive on segment-margin-adjusted multiples once you treat the camera-module rollup correctly.

The prime-wafer giants are not meaningful peers of RST — Shin-Etsu and SUMCO together set the global 300mm wafer price; GlobalWafers and Siltronic round out the top-4. None compete with RST in reclaim, and none compete in China at the scale of GRITEK. They are the read-through for prime-wafer pricing and the ceiling for what a clean prime-wafer pure-play earns through-cycle — not direct competitors.

Where The Company Wins

Four advantages, each grounded in disclosed evidence.

The reclaim margin durability point is worth seeing visually — it is the strongest single piece of evidence that this is not just a cyclical wafer name.

SUMCO and Siltronic figures are full-group operating margins as a proxy (both are essentially pure-play prime wafer); reclaim segment data from RST FY2024 Briefing 12-year segment table + FY2025 results. The point is the shape: RST reclaim stays in a 5.5-point band while pure-play prime margins traverse 25+ point ranges and dip into losses.

Where Competitors Are Better

RST is sub-scale in the prime wafer market and has structural disadvantages there. Five concrete weaknesses, by competitor.

The most important of these is #3 — customer diversification in prime. RST's prime wafer revenue is structurally hostage to Chinese mature-node demand because GRITEK cannot freely export to the US and EU, and because SGRS's 12-inch product is pre-commercial. The China-only exposure earns the prime segment a discounted multiple regardless of segment margin — which is why our valuation framework values that segment 5-8x EBIT versus 10-14x for the reclaim segment.

Threat Map

The threats to RST's competitive position split into competitor moves, substitute technologies, and regulatory shifts. Each is dated and sized for severity.

The highest-severity threat is Chinese state-backed new entrants competing with GRITEK for the same captive demand pool. This simultaneously caps the prime segment's terminal multiple and creates the largest realistic downside scenario — Chinese 8-inch / entry-level 12-inch oversupply would compress prime ASP further than the −10% YoY already booked in FY2025. The reclaim moat is far more durable than the prime moat.

Threat scoring (0–1) — Severity if it happens, Probability of happening, Imminence of impact.

Moat Watchpoints

Five measurable signals an investor should track quarterly to know whether the competitive position is improving or weakening. Each is observable in public filings or industry data within 30 days of the underlying event.

(1) Reclaim segment operating margin (RST Q briefing). The single best read on whether the moat is intact. Above 38% is healthy and consistent with the 2017-2024 average; below 35% structurally would indicate chemistry costs are rising, customer reclaim cycle counts are improving (i.e. they're using their own internal pool more), or RST is conceding price at LTA renewals. The number is disclosed every quarter in the results briefing PDF. Currently 36.9% (FY2025) — the lowest in three years; watch FY2026 trajectory carefully.

(2) RST reclaim wafer shipment volume vs SEMI silicon MSI shipments. Calculate RST's reclaim revenue growth as a ratio to the industry's wafer-area-shipped growth (SEMI quarterly release). A widening gap in RST's favor means market share is gaining; a narrowing or inverted gap means share is leaking — most likely to Ferrotec, Mimasu, or Kinik. RST claims 33% share; this is the closest public proxy for verifying it.

(3) Customer concentration / new customer wins in reclaim. Watch RST's top-customer disclosure annually (in the yuho risk-factor section). If revenue is moving toward more diversified customer base, the moat is broadening. If concentrating into a single fab cluster (e.g. Taiwan only), the moat is narrowing. Equally important: track named customer wins or losses cited in any RST press release or briefing.

(4) 8-inch prime wafer ASP trajectory at GRITEK + SGRS 12-inch qualification milestones. GRITEK is separately listed on Shanghai STAR Market (688521.SH) and discloses quarterly results. Its standalone numbers are the cleanest read on the prime segment without consolidation noise. ASP YoY change and any commentary on customer qualification for the 12-inch product are the key data points. FY2025: 8-inch volume +20% YoY but ASP −10% YoY — that mix is unsustainable into FY2026 if Chinese new entrants ramp.

(5) Ferrotec semi-equipment segment growth and capex direction. Ferrotec's FY3/24 results showed the semi-equipment + Other segment growing volume but compressing margin (12.5% vs 18.2% prior year), with heavy capex into Malaysia and Changshan. If Ferrotec's reclaim-adjacent capacity additions materialize at 200mm or 300mm, RST's reclaim segment ASP and utilization are the first metrics to feel it. Track Ferrotec's quarterly briefing decks.